These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11114303)

  • 1. Purification and characterization of A61. An angiostatin-like plasminogen fragment produced by plasmin autodigestion in the absence of sulfhydryl donors.
    Kassam G; Kwon M; Yoon CS; Graham KS; Young MK; Gluck S; Waisman DM
    J Biol Chem; 2001 Mar; 276(12):8924-33. PubMed ID: 11114303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonlysine-analog plasminogen modulators promote autoproteolytic generation of plasmin(ogen) fragments with angiostatin-like activity.
    Ohyama S; Harada T; Chikanishi T; Miura Y; Hasumi K
    Eur J Biochem; 2004 Feb; 271(4):809-20. PubMed ID: 14764098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen.
    Falcone DJ; Khan KM; Layne T; Fernandes L
    J Biol Chem; 1998 Nov; 273(47):31480-5. PubMed ID: 9813061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific proteolysis of human plasminogen by a 24 kDa endopeptidase from a novel Chryseobacterium Sp.
    Lijnen HR; Van Hoef B; Ugwu F; Collen D; Roelants I
    Biochemistry; 2000 Jan; 39(2):479-88. PubMed ID: 10631010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin.
    Stathakis P; Lay AJ; Fitzgerald M; Schlieker C; Matthias LJ; Hogg PJ
    J Biol Chem; 1999 Mar; 274(13):8910-6. PubMed ID: 10085135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p22 is a novel plasminogen fragment with antiangiogenic activity.
    Kwon M; Yoon CS; Fitzpatrick S; Kassam G; Graham KS; Young MK; Waisman DM
    Biochemistry; 2001 Nov; 40(44):13246-53. PubMed ID: 11683633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.
    Stack MS; Gately S; Bafetti LM; Enghild JJ; Soff GA
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):77-84. PubMed ID: 10229661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of macrophage receptor-bound plasmin by autoproteolysis.
    Falcone DJ; Borth W; McCaffrey TA; Mathew J; McAdam K
    J Biol Chem; 1994 Dec; 269(51):32660-6. PubMed ID: 7528219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells.
    Stathakis P; Fitzgerald M; Matthias LJ; Chesterman CN; Hogg PJ
    J Biol Chem; 1997 Aug; 272(33):20641-5. PubMed ID: 9252380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells.
    Cao Y; Ji RW; Davidson D; Schaller J; Marti D; Söhndel S; McCance SG; O'Reilly MS; Llinás M; Folkman J
    J Biol Chem; 1996 Nov; 271(46):29461-7. PubMed ID: 8910613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited plasmin proteolysis of vitronectin. Characterization of the adhesion protein as morpho-regulatory and angiostatin-binding factor.
    Kost C; Benner K; Stockmann A; Linder D; Preissner KT
    Eur J Biochem; 1996 Mar; 236(2):682-8. PubMed ID: 8612645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
    Sharma MR; Rothman V; Tuszynski GP; Sharma MC
    Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin.
    Tarui T; Majumdar M; Miles LA; Ruf W; Takada Y
    J Biol Chem; 2002 Sep; 277(37):33564-70. PubMed ID: 12087108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen.
    Heidtmann HH; Nettelbeck DM; Mingels A; Jäger R; Welker HG; Kontermann RE
    Br J Cancer; 1999 Dec; 81(8):1269-73. PubMed ID: 10604721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium falciparum proteases hydrolyze plasminogen, generating angiostatin-like fragments.
    Melo PM; Bagnaresi P; Paschoalin T; Hirata IY; Gazarini ML; Carmona AK
    Mol Biochem Parasitol; 2014 Jan; 193(1):45-54. PubMed ID: 24503144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells.
    Tuszynski GP; Sharma MR; Rothman VL; Sharma MC
    Microvasc Res; 2002 Nov; 64(3):448-62. PubMed ID: 12453439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth.
    Cao Y; Chen A; An SS; Ji RW; Davidson D; Llinás M
    J Biol Chem; 1997 Sep; 272(36):22924-8. PubMed ID: 9278456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
    Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
    Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a reduced form of plasma plasminogen as the precursor for angiostatin formation.
    Butera D; Wind T; Lay AJ; Beck J; Castellino FJ; Hogg PJ
    J Biol Chem; 2014 Jan; 289(5):2992-3000. PubMed ID: 24338014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant ascites fluid (MAF), including ovarian-cancer-associated MAF, contains angiostatin and other factor(s) which inhibit angiogenesis.
    Richardson M; Gunawan J; Hatton MW; Seidlitz E; Hirte HW; Singh G
    Gynecol Oncol; 2002 Sep; 86(3):279-87. PubMed ID: 12217749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.